Bibliographic Details
| Title: |
Ten-year survival benefit and appropriateness of surgical versus percutaneous revascularization in synergy between percutaneous coronary intervention with Taxus and cardiac surgery randomized trial. |
| Authors: |
Serruys, Patrick W, Ninomiya, Kai, Revaiah, Pruthvi C, Gao, Chao, Garg, Scot, Klaveren, David van, Onuma, Yoshinobu, Kappetein, Arie Pieter, Davierwala, Piroze, Mack, Michael, Thuijs, Daniel J F M, Taggart, David P, Milojevic, Milan |
| Source: |
European Journal of Cardio-Thoracic Surgery; Nov2024, Vol. 66 Issue 5, p1-10, 10p |
| Subject Terms: |
CORONARY artery bypass, CORONARY artery surgery, PERCUTANEOUS coronary intervention, REVASCULARIZATION (Surgery), CARDIAC surgery |
| Abstract: |
OBJECTIVES Average treatment effects from randomized trials do not reflect the heterogeneity of an individual's response to treatment. This study evaluates the appropriate proportions of patients for coronary artery bypass grafting, or percutaneous intervention based on the predicted/observed ratio of 10-year all-cause mortality in the SYNTAX population. METHODS The study included 1800 randomized patients and 1275 patients in the nested percutaneous (n = 198) or surgical (n = 1077) registries. The primary end point was 10-year all-cause mortality. The SYNTAX score II-2020 was validated internally in the randomized cohort and externally in the registry cohort. Proportions of patients with survival benefits from coronary artery bypass grafting or percutaneous intervention were determined using SYNTAX score II-2020. RESULTS Ten-year mortality was 23.8% for coronary artery bypass grafting, 28.6% for percutaneous intervention in the randomized cohort, 27.6% for coronary artery bypass grafting and 55.4% for percutaneous intervention in the registries. In the coronary artery bypass grafting registry, the SYNTAX score II-2020 predicted 10-year mortality with helpful calibration and discrimination (C-index: 0.70, intercept: 0.00, slope: 0.76). The proportion of patients deriving a predicted survival benefit from coronary artery bypass grafting over percutaneous intervention was 82.4% (2143/2602) and 17.7% (459/2602) for the entire SYNTAX trial population, translating into a 4.7 to 1 appropriate ratio of treatment allocation to coronary artery bypass grafting and percutaneous intervention. CONCLUSIONS Choosing a revascularization modality should depend on an individual's long-term prognosis rather than average treatment effects. Additionally, patients should be informed about their predicted prognosis. Trial registration Registered on clinicaltrial.gov SYNTAXES NCT03417050 (https://clinicaltrials.gov/ct2/show/NCT03417050) SYNTAX NCT00114972 (https://www.clinicaltrials.gov/ct2/show/NCT00114972) [ABSTRACT FROM AUTHOR] |
|
Copyright of European Journal of Cardio-Thoracic Surgery is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
